Literature DB >> 15965188

Optical coherence tomography in photodynamic therapy.

S Mennel, F Liu, C H Meyer.   

Abstract

Mesh:

Year:  2005        PMID: 15965188      PMCID: PMC1772721          DOI: 10.1136/bjo.2005.071092

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

1.  Immediate indocyanine green angiography and optical coherence tomography evaluation after photodynamic therapy for subfoveal choroidal neovascularization.

Authors:  Rogério A Costa; Michel E Farah; José A Cardillo; Daniela Calucci; George A Williams
Journal:  Retina       Date:  2003-04       Impact factor: 4.256

2.  Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization.

Authors:  Adam H Rogers; Adam Martidis; Paul B Greenberg; Carmen A Puliafito
Journal:  Am J Ophthalmol       Date:  2002-10       Impact factor: 5.258

3.  Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularisation secondary to age related macular degeneration: a cross sectional study.

Authors:  J Sahni; P Stanga; D Wong; S Harding
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

4.  Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration.

Authors:  T Daniel Ting; Mila Oh; Terry A Cox; Carsten H Meyer; Cynthia A Toth
Journal:  Arch Ophthalmol       Date:  2002-06

5.  [Transient visual decrease after photodynamic therapy].

Authors:  S Mennel; N Hausmann; C H Meyer; S Hörle; S Peter
Journal:  Ophthalmologe       Date:  2005-01       Impact factor: 1.059

  5 in total
  1 in total

1.  Optical coherence tomography analysis of a randomized study combining photodynamic therapy with intravitreal triamcinolone.

Authors:  L Arias; J Garcia-Arumi; J M Ramon; M Badia; M Rubio; O Pujol
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-03       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.